Treatment considerations: role of vagus nerve stimulator. (Q51950278)

18 April 2018

title

Treatment considerations: role of vagus nerve stimulator. (English)

1 reference

18 April 2018

author name string

Angus A. Wilfong

series ordinal

1

1 reference

18 April 2018

publication date

1 December 2002

1 reference

18 April 2018

published in

Epilepsy Behavior

1 reference

18 April 2018

volume

3

1 reference

18 April 2018

issue

6S1

1 reference

18 April 2018

page(s)

41-44

1 reference

18 April 2018

cites work

Vagus nerve stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Vagus nerve stimulation for control of intractable seizures in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: retrospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Vagus nerve stimulation for intractable epilepsy in children

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Vagus nerve stimulation treatment for Lennox-Gastaut syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Effects of 6 months of treatment with vagus nerve stimulation on behavior in children with lennox-gastaut syndrome in an open clinical and nonrandomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Effects of vagus nerve stimulation on progressive myoclonus epilepsy of Unverricht-Lundborg type

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Vagal nerve stimulation in the epileptic encephalopathies: 3-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Programmed and magnet-induced vagus nerve stimulation for refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Left vagal nerve stimulation in children with refractory epilepsy. Preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Vagus nerve stimulation is associated with mood improvements in epilepsy patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

A Pilot Study of Mood in Epilepsy Patients Treated with Vagus Nerve Stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Ventricular asystole during vagus nerve stimulation for epilepsy in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Bradycardia and asystole with the use of vagus nerve stimulation for the treatment of epilepsy: a rare complication of intraoperative device testing.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Epilepsy, vagal nerve stimulation by the NCP system, all-cause mortality, and sudden, unexpected, unexplained death

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

When drugs don't work: an algorithmic approach to medically intractable epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Vagus nerve stimulation for medication-resistant generalized epilepsy. E04 VNS Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Vagal nerve stimulation in tuberous sclerosis complex patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

Vagus nerve stimulation and drug reduction

1 reference

https://api.crossref.org/works/10.1016%2FS1525-5050%2802%2900541-3

7 January 2021

10.1016/S1525-5050(02)00541-3

Identifiers

DOI

1 reference

18 April 2018

1 reference

18 April 2018